Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patientsCatherine Patte, Mitchell S. Cairo, Claire Weston et al.|Blood|2006Cited by 431
Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescentsMitchell S. Cairo, Catherine Patte, Mary Gerrard et al.|Blood|2006Cited by 362
Excellent survival following two courses of COPAD chemotherapy in children and adolescents with resected localized B‐cell non‐Hodgkin’s lymphoma: results of the FAB/LMB 96 international study*Mary Gerrard, Catherine Patte, Sherrie L. Perkins et al.|British Journal of Haematology|2008Cited by 201